Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparation and characterization of visible-light-driven TiO2 photocatalyst Co-doped with nitrogen and erbium.

Journal of nanoscience and nanotechnology·2012
Same author

A novel sucrose phosphorylase from the metagenomes of sucrose-rich environment: isolation and characterization.

World journal of microbiology & biotechnology·2012
Same author

A metal-based inhibitor of tumor necrosis factor-α.

Angewandte Chemie (International ed. in English)·2012
Same author

[Effect of snail control of niclosamide by soil mixing and spraying methods in high dam of terrace].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2012
Same author

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency.

Neurobiology of aging·2012
Same author

[Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2012

Related Experiment Video

Updated: May 10, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

9.9K

Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic

Taimin Guo1, Yue Fu1, Xiaoyu Xu1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, China.

European Journal of Medical Research
|April 24, 2025
PubMed
Summary

Ethambutol-associated optic neuropathy (EON) shows significant visual function recovery between 3 and 6 months. Early intervention, especially for patients with temporal peripapillary retinal nerve fiber layer thinning, is crucial for maximizing visual recovery potential.

Keywords:
Ethambutol-induced neuropathyOptic neuropathy recoveryPrognosisRisk factorsVisual function

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.0K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.4K

Related Experiment Videos

Last Updated: May 10, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

9.9K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.0K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.4K

Area of Science:

  • Ophthalmology
  • Neuroscience

Background:

  • Ethambutol is a first-line treatment for tuberculosis.
  • Ethambutol-associated optic neuropathy (EON) is a potential vision-threatening side effect.
  • Understanding EON's temporal dynamics is crucial for patient management.

Purpose of the Study:

  • To investigate the temporal evolution of visual function and optic nerve structure in EON.
  • To identify factors influencing visual recovery and optic nerve changes in EON patients.

Main Methods:

  • Retrospective observational study of 48 EON patients with 12-month follow-up.
  • Comprehensive ophthalmologic assessments including BCVA, VF, OCT, and MRI.
  • Statistical analyses including multiple linear regression and comparative tests to identify influencing factors.

Main Results:

  • Significant improvements in BCVA and VF were observed between 3 and 6 months, indicating a critical recovery window.
  • Peripapillary retinal nerve fiber layer (pRNFL) thinning was most pronounced between 3 and 9 months, with the temporal quadrant showing earliest changes.
  • Disease course influenced VF recovery, while pRNFL thinning was associated with gender, ethambutol dosage, and disease duration; females showed slower pRNFL thinning.

Conclusions:

  • A critical recovery window for visual function in EON exists between 3 and 6 months.
  • Temporal pRNFL thinning may serve as an early marker for EON progression.
  • Early therapeutic interventions are recommended for EON patients, particularly those with temporal RNFL thinning, to maximize visual recovery.